Aaron Wolfe

Antoxerene, Inc. operates as a pharmaceutical company. It develops small molecule senolytic drugs for pathways of aging. The company was incorporated in 2016 and is headquartered in Lafayette, NY.

Lysoclear, Inc. owns and operates pharmaceuticals. It engages in treatment of age-related macular and Stargardt’s macular degeneration. The company is headquartered in Lafayette, NY.

Ichor Therapeutics, Inc. is a full-service contract research organization and American longevity biotechnology company. Ichor's CRO services help biotechnology and pharmaceutical companies solve their most difficult challenges, from preclinical studies to late-stage clinical trials and FDA approval, using a personalized approach that puts relationships and science first. As a longevity biotechnology company, Ichor aims to help people live longer, healthier lives by developing therapies with the potential to treat age-related diseases. The private company is pioneering the longevity and anti-aging biotechnology industry while empowering CRO clients to rapidly advance their research and development programs. The company was founded in 2013 in upstate New York and has subsidiaries in the United States. The CEO is Kelsey Moody.

Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia.